In one trial, atogepant was shown to reduce the number of migraine days a person had each month by 30%.
- Senior Lecturer and Director of Headache Research, Consultant clinical scientist; King's College London and Guy's and St Thomas' NHS Trust, King's College London
Contact Anna for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Location: London, UK
- Website
- X (formerly Twitter): @https://orcid.org/0000-0003-0892-6759
- Article Feed
- Joined
